ABSTRACT
but also associated with pathologic consequences related to obesity as dyslipidemia, hypertension, diabetes mellitus and atherosclerosis with its related vascular complications. (6) Epilepsy and antiepileptic drugs(AEDs) may alter weight homeostasis regulating process including the two main homeostatic hormones, leptin and insulin. Increased blood levels of leptin and insulin due to leptin and insulin resistances are observed in patients with epilepsy. (7, 8) Leptin controls weight homeostasis through two main neuropeptidergic systems that both project into the arcuate nucleus, neuropeptide Y(NPY) and pro-opiomelanocortin (POMC) expressing neurons. (9, 10) These neurons exert two opposite functions. NPY expressing neurons are anabolic, upon stimulation, food intake and metabolic efficiency are increased while energy expenditure is decreased. In contrast, the counterpart POMC expressing neurons are catabolic, upon stimulation, food intake and metabolic efficiency are decreased while energy expenditure is increased. (11) It has been reported that increased generation of free radicals or decreased activity of antioxidant defense systems can cause some forms of seizures and in addition can increase the risk of seizure recurrence. (12, 13) Many AEDs are metabolized to generate reactive metabolites with the capability of covalent binding to macromolecules as proteins or other vital biomolecules and hence eliciting systemic toxicity. (13, 14) Lipid peroxidation caused by increased generation of free radicals or decreased activity of antioxidant defense systems have been suggested to be critically involved in seizure control. (12) The aims of this study are to assess the effect of CBZ monotherapy in male epileptic patients on BMI, serum leptin, insulin and MDA levels (as a representative of oxidative stress), in comparison with healthy controls. 
Patients and methods

A. Epileptic patients
B. Control subjects
Forty apparently healthy male volunteers without previous history of epilepsy were recruited as controls with age matching to the patients group. The control group was judged free of any illness by history and clinical examination. They were included in the study to compare the normal values for serum leptin, insulin and MDA levels.
C. Specimen collection and analysis
Samples from the control (friends and relatives) and the patients were collected and assay of serum levels of leptin, insulin, MDA and TAS were done as in the patients group. Serum leptin was measured by enzyme linked immunosorbent assay (ELISA) technique, using the IBL leptin ELISA Kit (Germany), which is an immunoassay for the quantitative in vitro diagnostic measurment of leptin in serum and plasma. Serum insulin was also measured by ELISA kit (DRG-Germany). Serum MDA levels were measured using TBA assay method. (15) Body mass index (BMI) was calculated using the following equation: BMI= Weight (Kg)/ Height (m 2 ) (16) .
Statistical analysis
The data obtained in the current study were analyzed using Statistical Package for Social Sciences (SPSS) (version 16). Standard statistical methods were used to determine the mean and standard deviation. Unpaired t-test was used to compare the results of different biochemical parameters of epileptic adult patients with their matched controls. (19) Numerous studies reported weight gain with VPA in up to 50-70% of the patients. (3, 20, 21) Its etiology is most likely multi-factorial and controversial. Weight gain appears to be less a problem with CBZ than with VPA. The proposed mechanism of CBZ-associated weight gain can arise from edema but has also been associated with increased appetite and food consumption in the absence of edema. (22) The CBZ-induced edema has been postulated to be caused by drug-induced alterations in the secretion of antidiuretic hormone(ADH), although studies only inconsistently show an effect of the drug on plasma ADH levels. (23) Our study revealed insignificant effect of CBZ on BMI which is consistent with the studies of Biton, (24) and Uludag et al (25) but inconsistent with the studies of Richens et al (26) and Hogan et al. (27) They reported that between 15% and 25% of patients treated with CBZ developed weight gain. The two common homeostatic hormones, insulin and leptin have been expected to form a common link to weight gain in epilepsy with the use of some AEDs. Our study also revealed insignificant effect of CBZ on serum leptin level and insulin. Rauchenzauner et al, (28) compared two patient groups that use VPA and non-VPA AEDs regarding serum leptin and insulin levels. They concluded that non-VPA AEDs, (lamotrigine and oxcarbazepin) were thought to have no effect on leptin and insulin levels. There are a few studies such as ours that evaluate effect of CBZ treatment directly on serum leptin and insulin levels. Our findings are consistant with the results of Uludag etal and Hamed et al. (25, 29) Our study reported an elevated serum MDA level in epileptic male patients on CBZ therapy in comparison with healthy controls. Our findings are consistent with the results of the study conducted by Aycicek and Iscan. (30) They reported a markedly increased serum total peroxide levels in CBZ treated and untreated epileptic patients compared to healthy controls. Solowiej 
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